Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia

Journal of Chemotherapy

Volumn 19, Issue 4, 2007, Pages 382-387

  Réjiba, Samia ^a,b   Kechrid, A ^b  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b CHILDREN S HOSPITAL   (Tunisia)

Author keywords

Beta lactamases; Beta lactams; Escherichia coli; Resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM DERIVATIVE; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE TEM 1; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; PENICILLIN DERIVATIVE; PENICILLIN G; SULBACTAM; TICARCILLIN; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ESCHERICHIA COLI; ISOELECTRIC FOCUSING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; TUNISIA;

EID: 34547817728     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.4.382     Document Type: Article

References (24)

1. CTX-M genes. Clin Infect Dis 2004; 38: 1736-1741.
2. Piddock LJV, Walters RN, Jin YF, Turner HL, Gascoyne-Binzi DM, Hawkey PM. Prevalence and mechanism of resistance to "third-generation" cephalosporins in clinically relevant isolates of Enterobacteriaceae from 43 hospitals in the U. K., 1990-1991. J Antimicrob Chemother 1997; 39: 177-187.
3. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the western pacific region. Clin Infect Dis 2001; 32: S94-103.
4. Bush K, Jacoby GA, Medeiros AA. A functional classification schema for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-1233.
5. Chaibi EB, Sirot D, Paul G, Labia R. Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. J Antimicrob Chemother 1999; 43: 447-458.
6. Mirò E, Navarro F, Mirelis B, et al. Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a university hospital in Barcelona, Spain, over a 3-year period. Antimicrob Agents Chemother 2002; 46: 3991-3994.
7. Cao V, Lambert T, Nhu DQ, et al. Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother 2002; 46: 3739-3743.
8. Perilli M, Dell'Amico E, Segatore B, et al. Molecular charaterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an italian nationwide survey. J Clin Microbiol 2002; 40: 611-614.
9. Matsumoto Y, Ikeda F, Kamimura T, Yokota Y, Mine Y. Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oximino-cephalosporins. Antimicrob Agents Chemother 1988; 32; 1243-1246.
10. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
11. Alvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob Agents Chemother 2004; 48: 533-537.
12. Acar J, Carret G, Cavallo JD, et al. Comité de l'Antibiogramme de la Société Française de Microbiologie, communiqué 1998. Path Biol 1998; 46: I-XVI.
13. Réjiba S, Limam F, Belhadj C, Belhadj O, Ben-Mahrez K. Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802. Microb Drug Resist 2002; 8: 9-13.
14. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilising a principal protein-dye binding. Anal Biochem 1976; 72: 248-254.
15. Ben-Mahrez K, Réjiba S, Belhadj C, Belhadj O. beta-lactamase- mediated resistance to extended-spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa. Res Microbiol 1999; 150: 403-406.
16. Perret CJ. Iodometric assay of penicillinase. Nature 1954; 154: 1012-1013.
17. Quinteros M, Radice M, Gardella N, et al. Extended-spectrum beta-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob Agents Chemother 2003; 47: 2864-2867.
18. Sanguinetti M, Posteraro B, Spanu T, et al. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD phoenix extended-spectrum beta-lacta mase detection method. J Clin Microbiol 2003; 41: 1463-1468.
19. Mouneimné H, Robert J, Jarlier V, Cambau E. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999; 43: 62-66.
20. Oteo J, Campos J, Baquero F, Spanish members of the European Antimicrobial Resistance Surveillance System (EARSS). Antibiotic resistance in 1962 invasive isolates of Esherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001). J Antimicrob Chemother 2002; 50: 945-952.
21. Thomson KS, Weber DA, Sanders CC, Eugene Sanders Jr W. Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-Iactam-enzyme inhibitor combinations. Antimicrob Agents Chemother 1990; 34-. 622-627.
22. Smaoui H, Mahjoubi F, Boutiba I, et al. Antibiotic resistance among Escherichia coli isolates from urinary tract infections (1999-2000): a multicenter study. Tunis Med 2003; 81: 390-394.
23. Kim YK, Pai H, Lee HJ, et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002; 46; 1481-1491.
24. Kaye KS, Gold HS, Schwaber MJ, et al. Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United State. Antimicrob Agents Chemother 2004; 48: 1520-1525.